Loading...

Concord Medical Services Holdings

NYSE:CCM
Snowflake Description

Excellent balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CCM
NYSE
$132M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The last earnings update was 169 days ago. More info.


Add to Portfolio Compare Print
  • Concord Medical Services Holdings has significant price volatility in the past 3 months.
CCM Share Price and Events
7 Day Returns
-1.5%
NYSE:CCM
-0.8%
US Healthcare
0.5%
US Market
1 Year Returns
18.1%
NYSE:CCM
9.3%
US Healthcare
2%
US Market
CCM Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Concord Medical Services Holdings (CCM) -1.5% -5.6% -17.8% 18.1% -36.9% -58.4%
US Healthcare -0.8% 5.4% -3.6% 9.3% 40.3% 88%
US Market 0.5% 6.3% 1.9% 2% 45.1% 40.5%
1 Year Return vs Industry and Market
  • CCM outperformed the Healthcare industry which returned 9.3% over the past year.
  • CCM outperformed the Market in United States of America which returned 2% over the past year.
Price Volatility
CCM
Industry
5yr Volatility vs Market

CCM Value

 Is Concord Medical Services Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Concord Medical Services Holdings. This is due to cash flow or dividend data being unavailable. The share price is $3.04.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Concord Medical Services Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Concord Medical Services Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:CCM PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in CNY CN¥-7.18
NYSE:CCM Share Price ** NYSE (2019-02-13) in USD $3.04
NYSE:CCM Share Price converted to CNY reporting currency Exchange rate (USD/ CNY) 6.762 CN¥20.56
United States of America Healthcare Industry PE Ratio Median Figure of 52 Publicly-Listed Healthcare Companies 21.6x
United States of America Market PE Ratio Median Figure of 3,046 Publicly-Listed Companies 16.95x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Concord Medical Services Holdings.

NYSE:CCM PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:CCM Share Price ÷ EPS (both in CNY)

= 20.56 ÷ -7.18

-2.86x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Concord Medical Services Holdings is loss making, we can't compare its value to the US Healthcare industry average.
  • Concord Medical Services Holdings is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Concord Medical Services Holdings's expected growth come at a high price?
Raw Data
NYSE:CCM PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.86x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
Not available
United States of America Healthcare Industry PEG Ratio Median Figure of 39 Publicly-Listed Healthcare Companies 1.49x
United States of America Market PEG Ratio Median Figure of 2,117 Publicly-Listed Companies 1.36x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Concord Medical Services Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Concord Medical Services Holdings's assets?
Raw Data
NYSE:CCM PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in CNY CN¥18.48
NYSE:CCM Share Price * NYSE (2019-02-13) in USD $3.04
NYSE:CCM Share Price converted to CNY reporting currency Exchange rate (USD/ CNY) 6.762 CN¥20.56
United States of America Healthcare Industry PB Ratio Median Figure of 91 Publicly-Listed Healthcare Companies 2.49x
United States of America Market PB Ratio Median Figure of 5,122 Publicly-Listed Companies 1.81x
NYSE:CCM PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:CCM Share Price ÷ Book Value per Share (both in CNY)

= 20.56 ÷ 18.48

1.11x

* Primary Listing of Concord Medical Services Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Concord Medical Services Holdings is good value based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Concord Medical Services Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Concord Medical Services Holdings has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

CCM Future Performance

 How is Concord Medical Services Holdings expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-0.1%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is Concord Medical Services Holdings expected to grow at an attractive rate?
  • Unable to compare Concord Medical Services Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Concord Medical Services Holdings's earnings growth to the United States of America market average as no estimate data is available.
  • Concord Medical Services Holdings's revenues are expected to decrease over the next 1-3 years, this is below the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:CCM Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:CCM Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts -0.1%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 16.2%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 7.8%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:CCM Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (7 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CNY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:CCM Future Estimates Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 232 1
2019-12-31 236 1
2018-12-31 240 1
NYSE:CCM Past Financials Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income *
2018-06-30 230 -311
2018-03-31 280 -297
2017-12-31 331 27 -284
2017-09-30 369 -299
2017-06-30 407 -313
2017-03-31 433 -281
2016-12-31 455 -78 -262
2016-09-30 492 -322
2016-06-30 546 -194
2016-03-31 591 -139
2015-12-31 616 -175 -78
2015-09-30 405 96

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Concord Medical Services Holdings is high growth as no earnings estimate data is available.
  • Concord Medical Services Holdings's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:CCM Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (7 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Concord Medical Services Holdings Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:CCM Future Estimates Data
Date (Data in CNY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31
2019-12-31
2018-12-31
NYSE:CCM Past Financials Data
Date (Data in CNY Millions) EPS *
2018-06-30 -7.18
2018-03-31 -6.87
2017-12-31 -6.56
2017-09-30 -6.88
2017-06-30 -7.21
2017-03-31 -6.46
2016-12-31 -6.01
2016-09-30 -7.34
2016-06-30 -4.38
2016-03-31 -3.12
2015-12-31 -1.75
2015-09-30 2.13

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Concord Medical Services Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Concord Medical Services Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Concord Medical Services Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

CCM Past Performance

  How has Concord Medical Services Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Concord Medical Services Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Concord Medical Services Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Concord Medical Services Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Concord Medical Services Holdings's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Concord Medical Services Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Concord Medical Services Holdings Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:CCM Past Revenue, Cash Flow and Net Income Data
Date (Data in CNY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 229.85 -310.67 259.91
2018-03-31 280.41 -297.49 270.58
2017-12-31 330.98 -284.32 281.25
2017-09-30 368.81 -298.80 293.34
2017-06-30 406.65 -313.28 305.43
2017-03-31 433.16 -280.60 288.99
2016-12-31 455.04 -261.87 276.00
2016-09-30 491.78 -321.74 272.96
2016-06-30 545.88 -193.72 255.78
2016-03-31 590.80 -138.99 258.60
2015-12-31 616.49 -78.30 245.77
2015-09-30 405.28 95.69 198.14
2015-06-30 504.21 103.70 167.63
2015-03-31 614.96 102.17 153.62
2014-12-31 606.88 99.23 148.67
2014-09-30 552.34 90.77 168.66
2014-06-30 1,060.61 98.79 207.86
2014-03-31 501.83 81.03 189.70
2013-12-31 563.12 75.13 189.17
2013-09-30 904.96 107.02 172.90
2013-06-30 877.05 118.20 161.57
2013-03-31 759.53 126.34 142.58
2012-12-31 455.65 123.24 115.02
2012-09-30 563.47 -211.37 137.59
2012-06-30 482.13 -211.90 131.53
2012-03-31 469.45 -213.19 123.09

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Concord Medical Services Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Concord Medical Services Holdings has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Concord Medical Services Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Concord Medical Services Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Concord Medical Services Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

CCM Health

 How is Concord Medical Services Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Concord Medical Services Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Concord Medical Services Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Concord Medical Services Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Concord Medical Services Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Concord Medical Services Holdings Company Filings, last reported 7 months ago.

NYSE:CCM Past Debt and Equity Data
Date (Data in CNY Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 2,534.68 1,061.05 459.97
2018-03-31 2,534.68 1,061.05 459.97
2017-12-31 1,411.20 1,593.52 98.19
2017-09-30 1,411.20 1,593.52 98.19
2017-06-30 1,136.37 2,140.85 608.20
2017-03-31 1,136.37 2,140.85 608.20
2016-12-31 1,231.77 1,717.79 189.91
2016-09-30 1,231.77 1,717.79 189.91
2016-06-30 1,394.03 1,596.07 164.01
2016-03-31 1,398.84 1,730.87 181.29
2015-12-31 1,433.79 1,599.14 545.44
2015-09-30 1,863.71 1,135.60 158.37
2015-06-30 1,868.52 1,047.31 461.99
2015-03-31 1,832.49 841.91 572.93
2014-12-31 1,800.06 903.84 478.68
2014-09-30 2,094.12 1,151.60 246.99
2014-06-30 2,299.38 1,041.38 318.97
2014-03-31 2,258.58 1,105.68 221.45
2013-12-31 2,433.72 1,086.25 283.03
2013-09-30 2,419.84 965.61 166.56
2013-06-30 2,391.73 1,026.22 215.03
2013-03-31 2,358.57 1,013.24 181.51
2012-12-31 2,339.91 877.57 75.38
2012-09-30 2,345.94 471.05 324.02
2012-06-30 2,083.99 284.15 130.73
2012-03-31 2,051.79 265.36 281.65
  • Concord Medical Services Holdings's level of debt (41.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (42.9% vs 41.9% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Concord Medical Services Holdings has sufficient cash runway for 1.7 years based on current free cash flow.
  • Concord Medical Services Holdings has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of -15.8% each year.
X
Financial health checks
We assess Concord Medical Services Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Concord Medical Services Holdings has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

CCM Dividends

 What is Concord Medical Services Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Concord Medical Services Holdings dividends. Estimated to be 0% next year.
If you bought $2,000 of Concord Medical Services Holdings shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Concord Medical Services Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Concord Medical Services Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:CCM Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 23 Stocks 1.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1997 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:CCM Future Dividends Estimate Data
Date (Data in CN¥) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00
2018-12-31 0.00 1.00
NYSE:CCM Past Annualized Dividends Data
Date (Data in CN¥) Dividend per share (annual) Avg. Yield (%)
2017-08-25 0.000 0.000
2017-05-01 0.000 0.000
2015-12-11 6.390 22.237
2013-03-20 0.000 0.000
2012-11-21 0.000 0.000
2012-11-20 0.000 0.000
2012-08-20 0.000 0.000
2012-05-21 0.000 0.000
2012-04-25 0.000 0.000
2010-06-30 0.731 2.304
2010-03-19 0.731 1.625
2009-12-11 0.731 1.185

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Concord Medical Services Holdings has not reported any payouts.
  • Unable to verify if Concord Medical Services Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Concord Medical Services Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Concord Medical Services Holdings has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Concord Medical Services Holdings's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Concord Medical Services Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Concord Medical Services Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Concord Medical Services Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

CCM Management

 What is the CEO of Concord Medical Services Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jianyu Yang
COMPENSATION CN¥0
AGE 47
TENURE AS CEO 11.1 years
CEO Bio

Dr. Jianyu Yang has been the Chief Executive Officer at Concord Medical Services Holdings Limited since 2008 and served as its President from 2008 to November 27, 2011. Dr. Yang served as the Chief Executive Officer of Eguard Resource Development Co., Ltd., a PRC company listed on the Shenzhen Stock Exchange in China principally engaged in the provision of comprehensive solutions in recycling, re-use of solid wastes and wastewater since 2003, vice president of Beijing Sound Environmental Group Co. Ltd. from 2002 to 2003, Assistant to the General Manager of Xiangcai Securities Co., Ltd. from 2000 to 2002 and Senior Economist at China Agricultural Bank from 1999 to 2000. He has been the Chairman of the Board at Concord Medical Services Holdings Limited since November 27, 2011 and has been Director since 2008. Dr. Yang received a doctorate degree in economics from Liaoning University in 1999 in China.

CEO Compensation
  • Insufficient data for Jianyu to compare compensation growth.
  • Jianyu's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure of the Concord Medical Services Holdings management team in years:

7.3
Average Tenure
  • The average tenure for the Concord Medical Services Holdings management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Jianyu Yang

TITLE
Chairman & CEO
AGE
47
TENURE
11.1 yrs

Kong Yap Yaw

TITLE
Chief Financial Officer
AGE
54
TENURE
4.6 yrs

Xun Liu

TITLE
Financial Controller
TENURE
7.3 yrs
Board of Directors Tenure

Average tenure and age of the Concord Medical Services Holdings board of directors in years:

7.3
Average Tenure
49
Average Age
  • The tenure for the Concord Medical Services Holdings board of directors is about average.
Board of Directors

Jianyu Yang

TITLE
Chairman & CEO
AGE
47
TENURE
7.3 yrs

Denny Lee

TITLE
Independent Non-Executive Director
AGE
51
TENURE
9.2 yrs

Zheng Cheng

TITLE
Director
AGE
55
TENURE
11.1 yrs

Weibo Yin

TITLE
Independent Director
AGE
87
TENURE
7.3 yrs

Shang Chuang

TITLE
Director
AGE
36
TENURE
1.6 yrs

Liping Zhang

TITLE
Independent Director
AGE
46
TENURE
1.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Concord Medical Services Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Concord Medical Services Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

CCM News

Simply Wall St News

What You Must Know About Concord Medical Services Holdings Limited's (NYSE:CCM) Financial Strength

While small-cap stocks, such as Concord Medical Services Holdings Limited (NYSE:CCM) with its market cap of US$160m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

Does Concord Medical Services Holdings Limited's (NYSE:CCM) -8.57% Earnings Drop Reflect A Longer Term Trend?

When Concord Medical Services Holdings Limited (NYSE:CCM) released its most recent earnings update (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of its industry peers on average. … Being able to interpret how well Concord Medical Services Holdings has done so far requires weighing its performance against a benchmark, rather than looking at a standalone number at a point in time. … CCM is loss-making, with the most recent trailing twelve-month earnings of -CN¥284.32m (from 31 December 2017), which compared to last year has become

Simply Wall St -

Should You Be Concerned About Concord Medical Services Holdings Limited's (NYSE:CCM) Investors?

Today, I will be analyzing Concord Medical Services Holdings Limited’s (NYSE:CCM) recent ownership structure, an important but not-so-popular subject among individual investors. … The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment. … View our latest analysis for Concord Medical Services Holdings

Simply Wall St -

How Financially Strong Is Concord Medical Services Holdings Limited (NYSE:CCM)?

Investors are always looking for growth in small-cap stocks like Concord Medical Services Holdings Limited (NYSE:CCM), with a market cap of CN¥163.48m. … However, an important fact which most ignore is: how financially healthy is the business?

Simply Wall St -

Is Concord Medical Services Holdings Limited's (NYSE:CCM) Balance Sheet A Threat To Its Future?

Investors are always looking for growth in small-cap stocks like Concord Medical Services Holdings Limited (NYSE:CCM), with a market cap of US$179.09m. … However, an important fact which most ignore is: how financially healthy is the business?

Simply Wall St -

Who Are The Top Investors In Concord Medical Services Holdings Limited (NYSE:CCM)?

Check out our latest analysis for Concord Medical Services Holdings NYSE:CCM Ownership_summary May 21st 18 Institutional Ownership Due to the big order sizes of institutional investors, a company's shares can experience large, one-sided momentum, driven by high volume of shares removed from, or injected into, the market. … Apart from low institutional ownership, another indicator of CCM's low popularity is the fact that the company is only covered by 1 analyst. … With this size of ownership, retail investors can collectively play a role in major company policies that affect shareholders returns, including executive remuneration and the appointment of directors.

Simply Wall St -

What Is Concord Medical Services Holdings Limited's (NYSE:CCM) Share Price Doing?

Concord Medical Services Holdings Limited (NYSE:CCM), a healthcare company based in China, received a lot of attention from a substantial price increase on the NYSE over the last few months. … I find that Concord Medical Services Holdings’s ratio of 1.04x is trading slightly below its industry peers’ ratio of 2.62x, which means if you buy Concord Medical Services Holdings today, you’d be paying a relatively reasonable price for it. … What kind of growth will Concord Medical Services Holdings generate?

Simply Wall St -

Was Concord Medical Services Holdings Limited's (NYSE:CCM) Earnings Decline Part Of A Broader Industry Downturn?

See our latest analysis for Concord Medical Services Holdings Was CCM's recent earnings decline indicative of a tough track record? … For Concord Medical Services Holdings, its most recent trailing-twelve-month earnings is -CN¥313.28M, which compared to the previous year's figure, has become more negative. … NYSE:CCM Income Statement Apr 6th 18 We can further analyze Concord Medical Services Holdings's loss by looking at what the industry has been experiencing over the past few years.

Simply Wall St -

Is Concord Medical Services Holdings Limited's (NYSE:CCM) Balance Sheet A Threat To Its Future?

How does CCM’s operating cash flow stack up against its debt? … Moving onto cash from operations, its operating cash flow is not yet significant enough to calculate a meaningful cash-to-debt ratio, indicating that operational efficiency is something we’d need to take a look at. … Maintaining a high level of debt, while revenues are still below costs, can be dangerous as liquidity tends to dry up in unexpected downturns.Next Steps: CCM’s cash flow coverage indicates it could improve its operating efficiency in order to meet demand for debt repayments should unforeseen events arise.

Simply Wall St -

What Does Concord Medical Services Holdings Limited's (NYSE:CCM) Share Price Indicate?

Concord Medical Services Holdings Limited (NYSE:CCM), a healthcare company based in China, saw significant share price volatility over the past couple of months on the NYSE, rising to the highs of $4 and falling to the lows of $3.4. … The stock’s ratio of 0.9x is currently trading slightly below its industry peers’ ratio of 2.6x, which means if you buy Concord Medical Services Holdings today, you’d be paying a relatively fair price for it. … And if you believe Concord Medical Services Holdings should be trading in this range, then there isn’t much room for the share price grow beyond what it’s currently trading.

Simply Wall St -

CCM Company Info

Map
Description

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The company’s services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. It also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions, as well as CT scanners and ECT scanners for diagnostic imaging. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as consulting services; sells medical equipment; and researches and develops medical technology. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2017, it operated a network of 44 cooperative centers based in 30 hospitals in 29 cities across 18 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People’s Republic of China.

Details
Name: Concord Medical Services Holdings Limited
CCM
Exchange: NYSE
Founded: 2007
$131,891,895
43,385,492
Website: http://www.concordmedical.com
Address: Concord Medical Services Holdings Limited
Tower A, Global Trade Center,
18th Floor,
Beijing,
100013,
China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE CCM ADS EACH 1 REPR 3 ORD SHS (USD0.0001) New York Stock Exchange US USD 11. Dec 2009
DB C2CA ADS EACH 1 REPR 3 ORD SHS (USD0.0001) Deutsche Boerse AG DE EUR 11. Dec 2009
Number of employees
Current staff
Staff numbers
583
Concord Medical Services Holdings employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/14 00:35
End of day share price update: 2019/02/13 00:00
Last estimates confirmation: 2019/01/08
Last earnings filing: 2018/08/29
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.